These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35121582)

  • 21. Prostaglandin E Receptor 4 Antagonist in Cancer Immunotherapy: Mechanisms of Action.
    Take Y; Koizumi S; Nagahisa A
    Front Immunol; 2020; 11():324. PubMed ID: 32210957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin E2-stimulated prostanoid EP4 receptors induce prolonged de novo prostaglandin E2 synthesis through biphasic phosphorylation of extracellular signal-regulated kinases mediated by activation of protein kinase A in HCA-7 human colon cancer cells.
    Fujino H; Seira N; Kurata N; Araki Y; Nakamura H; Regan JW; Murayama T
    Eur J Pharmacol; 2015 Dec; 768():149-59. PubMed ID: 26518053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COX-1/PGE
    Peng X; Li J; Tan S; Xu M; Tao J; Jiang J; Liu H; Wu B
    Sci Rep; 2017 Apr; 7(1):1055. PubMed ID: 28432343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EP4 as a Therapeutic Target for Aggressive Human Breast Cancer.
    Majumder M; Nandi P; Omar A; Ugwuagbo KC; Lala PK
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29596308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin E
    Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ
    Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism.
    Schmidt A; Sinnett-Smith J; Young S; Chang HH; Hines OJ; Dawson DW; Rozengurt E; Eibl G
    Surgery; 2017 Jun; 161(6):1570-1578. PubMed ID: 28222855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
    Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
    J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of the S1P
    Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
    Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LDL-Dependent Regulation of TNFα/PGE
    Neuschäfer-Rube F; Schön T; Kahnt I; Püschel GP
    Inflammation; 2023 Jun; 46(3):893-911. PubMed ID: 36598592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
    Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
    Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A RIPK3-PGE
    Yan G; Zhao H; Zhang Q; Zhou Y; Wu L; Lei J; Wang X; Zhang J; Zhang X; Zheng L; Du G; Xiao W; Tang B; Miao H; Li Y
    Cancer Res; 2018 Oct; 78(19):5586-5599. PubMed ID: 30012671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance to 3-HTMC-Induced Apoptosis Through Activation of PI3K/Akt, MEK/ERK, and p38/COX-2/PGE
    Semaan J; Pinon A; Rioux B; Hassan L; Limami Y; Pouget C; Fagnère C; Sol V; Diab-Assaf M; Simon A; Liagre B
    J Cell Biochem; 2016 Dec; 117(12):2875-2885. PubMed ID: 27192488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of PGE
    Huang H; Aladelokun O; Ideta T; Giardina C; Ellis LM; Rosenberg DW
    Sci Rep; 2019 Mar; 9(1):4954. PubMed ID: 30894570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/+ mice.
    Moran AE; Hunt DH; Javid SH; Redston M; Carothers AM; Bertagnolli MM
    J Biol Chem; 2004 Oct; 279(41):43261-72. PubMed ID: 15294912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.
    Paul AG; Chandran B; Sharma-Walia N
    Transl Res; 2013 Aug; 162(2):77-92. PubMed ID: 23567332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PGE
    Lin MC; Chen SY; Tsai HM; He PL; Lin YC; Herschman H; Li HJ
    Stem Cells; 2017 Feb; 35(2):425-444. PubMed ID: 27506158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin E2-EP4 receptor signalling promotes tumorigenic behaviour of HT-29 human colorectal cancer cells.
    Hawcroft G; Ko CW; Hull MA
    Oncogene; 2007 May; 26(21):3006-19. PubMed ID: 17130837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer.
    Akbari B; Soltantoyeh T; Shahosseini Z; Jadidi-Niaragh F; Hadjati J; Brown CE; Mirzaei HR
    Front Immunol; 2023; 14():1209572. PubMed ID: 37457723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced Immunotherapeutic Efficacy of Anti-PD-L1 Antibody in Combination with an EP4 Antagonist.
    Sajiki Y; Konnai S; Cai Z; Takada K; Okagawa T; Maekawa N; Fujisawa S; Kato Y; Suzuki Y; Murata S; Ohashi K
    Immunohorizons; 2020 Dec; 4(12):837-850. PubMed ID: 33443026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin E
    Wan M; Tang X; Rekha RS; Muvva SSVJR; Brighenti S; Agerberth B; Haeggström JZ
    FASEB J; 2018 May; 32(5):2827-2840. PubMed ID: 29401596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.